SMART-TRIAL is attending The 2nd World Congress on Regulatory Affairs for Medical Devices (RAMD) held in London, United Kingdom, from the 2nd to the 3rd of July.
Vice President of Business Development and Cofounder Jón I. Bergsteinsson will attend for the second year in a row. But this time as a speaker. In his talk, he will explain the importance of optimizing the generation of clinical evidence for medical devices. The talk will take place on the 2nd of July from 11:00 am to 11:40 am at the Hilton Hotel Wembley.The content of the talk will include the challenges and benefits of generating clinical evidence for medical device companies. Also, why manufacturers should focus on improving the whole process, and not just the tools. Additionally, optimization can cut down time spent on planning for clinical investigation, from weeks (and sometimes months) to, days. The storage of clinical evidence is safe, secure, and accessible.
"With the changes brought about by the MDR, it is important for industry leaders to start reevaluating their clinical operations. Not only how evidence is collected but also how their processes can be optimized"
Says Jón Ingi Bergsteinsson
Visit: http://www.ramd2018.com/congress-program.aspxAbout SMART-TRIALSMART-TRIAL is an intelligent data management solution for better medical devices. The Software as a Service (SaaS) is essential for medical device manufacturers to illustrate the quality and safety of their medical device. Improving the collection and management of data and reducing chaos.Visit: https://www.smart-trial.co/For further information and images, please contact:Jón Ingi BergsteinssonMEDEI ApSVice President for Global Business DevelopmentTel: +45 42 70 70 03Email: jib@medei.dk